| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.253 | 35.346 | 82.260 | 351.378 | 730.052 | 1.084.999 | 1.450.700 |
| Total Income - EUR | - | - | - | 4.253 | 35.402 | 82.343 | 351.389 | 765.638 | 1.148.111 | 1.534.054 |
| Total Expenses - EUR | - | - | - | 4.680 | 16.867 | 47.417 | 114.564 | 478.054 | 1.090.617 | 1.252.674 |
| Gross Profit/Loss - EUR | - | - | - | -427 | 18.535 | 34.927 | 236.825 | 287.584 | 57.494 | 281.380 |
| Net Profit/Loss - EUR | - | - | - | -432 | 18.182 | 34.149 | 234.024 | 282.458 | 47.290 | 253.691 |
| Employees | - | - | - | 1 | 1 | 2 | 2 | 6 | 13 | 14 |
Check the financial reports for the company - Dexa Diagnostic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 25.574 | 44.187 | 60.520 | 272.134 | 1.573.470 | 1.734.968 | 1.688.659 |
| Current Assets | - | - | - | 2.861 | 3.253 | 22.315 | 106.981 | 613.653 | 668.126 | 674.574 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 4.156 | 1.046 | 1.144 |
| Receivables | - | - | - | 0 | 224 | 1.003 | 15.880 | 554.058 | 663.037 | 559.474 |
| Cash | - | - | - | 2.861 | 3.029 | 21.311 | 91.100 | 55.439 | 4.042 | 113.955 |
| Shareholders Funds | - | - | - | -389 | 17.785 | 51.597 | 284.476 | 567.817 | 596.904 | 756.043 |
| Social Capital | - | - | - | 43 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | - | 28.824 | 29.804 | 31.321 | 94.638 | 1.122.256 | 1.203.716 | 1.088.393 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 497.187 | 603.178 | 519.112 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Dexa Diagnostic S.r.l.